Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value
$159.65M
Total Bought
$43.57M
Total Sold
$52.07M
Net Transaction
-$8.50M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SUTRO BIOPHARMA INC(STRO)312,000512,160+200,1603,61012,7587.99%+9,148
TENAX THERAPEUTICS INC(TENX)83,333583,333+500,0001,0169,3275.84%+8,312
IMMIX BIOPHARMA INC(IMMX)35,000740,000+705,0001836,7414.22%+6,558
ANTERIS TECHNOLOGIES GLOBAL(AVR)0700,000+700,00003,8852.43%+3,885
EDESA BIOTECH INC(EDSA)687,500827,500+140,0009764,3282.71%+3,352
XENCOR INC(XNCR)0250,000+250,00003,0151.89%+3,015
PRAXIS PRECISION MEDICINES I(PRAX)100,781100,781029,70432,47120.34%+2,766
CYTOMX THERAPEUTICS INC.(CTMX)80,000540,000+460,0003412,5381.59%+2,197
LYELL IMMUNOPHARMA INC(LYEL)0102,000+102,00002,0461.28%+2,046
EVOMMUNE INC(EVMN)506,754446,255-60,4998,67610,2596.43%+1,584
ROCKET PHARMACEUTICALS INC(RCKT)0294,643+294,64301,0550.66%+1,055
MAPLIGHT THERAPEUTICS INC(MPLT)522,305492,893-29,4129,17410,0216.28%+846
NASUS PHARMA LTD(NSRX)0359,390+359,39007980.50%+798
QUOIN PHARMACEUTICALS LTD(QNRX)084,849+84,84905600.35%+560
REZOLUTE INC(RZLT)750,000750,00001,7702,2881.43%+518
ESPERION THERAPEUTICS INC NE1,210,0001,720,000+510,0004,4774,7132.95%+236
ARTIVA BIOTHERAPEUTICS INC(ARTV)025,000+25,00001610.10%+161
NEUMORA THERAPEUTICS INC.(NMRA)080,000+80,00001560.10%+156
CORBUS PHARMACEUTICALS HLDGS(CRBP)13,00026,000+13,0001062440.15%+138
PRECISION BIOSCIENCES INC(DTIL)20,00040,000+20,000832200.14%+137
XILIO THERAPEUTICS INC(XLO)014,285+14,28501200.08%+120
CONTEXT THERAPEUTICS INC(CNTX)100,000100,00001472620.16%+115
KALARIS THERAPEUTICS INC(KLRS)018,000+18,00001040.07%+104
OVID THERAPEUTICS INC(OVID)160,000160,00002613550.22%+94
MACROGENICS INC(MGNX)030,000+30,0000870.05%+87
KARYOPHARM THERAPEUTICS INC(KPTI)015,000+15,0000840.05%+84
PROTAGONIST THERAPEUTICS INC3,7003,70003233900.24%+67
PMV PHARMACEUTICALS INC(PMVP)35,00073,000+38,00044910.06%+47
DESIGN THERAPEUTICS INC(DSGN)20,00020,00001882130.13%+25
LARIMAR THERAPEUTICS INC(LRMR)33,00033,00001261490.09%+23
REPLIMUNE GROUP INC(REPL)15,00020,000+5,0001461530.10%+7
IMMUNOME INC(IMNM)10,00010,00002152190.14%+4
PROQR THRAPEUTICS N V
SHS EURO
45,00045,000091730.05%-18
ARROWHEAD PHARMACEUTICALS IN(ARWR)6,5006,50004324080.26%-24
PYXIS ONCOLOGY INC(PYXS)40,0000-40,000460—-46
NURIX THERAPEUTICS INC(NRIX)16,00016,00003042480.16%-56
XILIO THERAPEUTICS INC(XLO)170,0000-170,0001090—-109
EUPRAXIA PHARMACEUTICALS INC(EPRX)352,000352,00002,6582,5481.60%-109
GOSSAMER BIO INC(GOSS)70,00070,0000217230.01%-194
PROTARA THERAPEUTICS INC(TARA)2,834,6522,834,652015,10914,7699.25%-340
VENTYX BIOSCIENCES INC40,0000-40,0003610—-361
INSPIREMD INC(NSPR)2,143,6982,099,652-44,0463,8163,4222.14%-393
PROFOUND MED CORP(PROF)285,710285,71002,2491,8511.16%-397
ABIVAX SA(ABVX)67,00077,000+10,0009,0358,5745.37%-461
VIRIDIAN THERAPEUTICS INC(VRDN)86,50091,123+4,6232,6921,7821.12%-910
KAZIA THERAPEUTICS LTD(KZIA)300,000135,315-164,6852,0671,0070.63%-1,060
VERRICA PHARMACEUTICALS INC(VRCA)471,559471,55903,9192,4951.56%-1,424
AVALO THERAPEUTICS INC(AVTX)263,642185,122-78,5204,7882,7641.73%-2,024
SYNDAX PHARMACEUTICALS INC(SNDX)130,00010,000-120,0002,7312340.15%-2,498
JASPER THERAPEUTICS INC(JSPR)2,668,3952,668,39504,8832,3381.46%-2,545
TREVI THERAPEUTICS INC(TRVI)205,0000-205,0002,5670—-2,567
TERNS PHARMACEUTICALS INC70,0000-70,0002,8280—-2,828
RAPT THERAPEUTICS INC108,0000-108,0003,6580—-3,658
HERON THERAPEUTICS INC(HRTX)8,753,2908,753,290011,3797,0044.39%-4,376
LANTHEUS HLDGS INC(LNTH)74,6870-74,6874,9700—-4,970
MINERALYS THERAPEUTICS INC(MLYS)151,00011,000-140,0005,4802980.19%-5,182
CIDARA THERAPEUTICS INC108,4040-108,40423,9450—-23,945
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q1 2026 | TickerTrail